These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 21289515)

  • 21. [Von Willebrand disease: from diagnosis to treatment].
    Fressinaud E; Meyer D
    Rev Prat; 2005 Dec; 55(20):2209-18. PubMed ID: 16519045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.
    Sadler JE; Budde U; Eikenboom JC; Favaloro EJ; Hill FG; Holmberg L; Ingerslev J; Lee CA; Lillicrap D; Mannucci PM; Mazurier C; Meyer D; Nichols WL; Nishino M; Peake IR; Rodeghiero F; Schneppenheim R; Ruggeri ZM; Srivastava A; Montgomery RR; Federici AB;
    J Thromb Haemost; 2006 Oct; 4(10):2103-14. PubMed ID: 16889557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevalence, pathophysiology, diagnosis and treatment of von Willebrand syndrome in orthopedic trauma patients].
    Kurth AA; Ludwig G; Scharrer I
    Orthopade; 1999 Apr; 28(4):366-74. PubMed ID: 10335531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and management of von Willebrand disease.
    Federici AB; Mannucci PM
    Haemophilia; 1999 May; 5 Suppl 2():28-37. PubMed ID: 23401897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Von Willebrand disease : diagnosis and management].
    Antony C; Rossaint R; Schaelte G
    Internist (Berl); 2010 Sep; 51(9):1118, 1120-6. PubMed ID: 20012256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guidelines for the diagnosis and management of von Willebrand disease in Italy.
    Federici AB; Castaman G; Mannucci PM;
    Haemophilia; 2002 Sep; 8(5):607-21. PubMed ID: 12199668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function.
    Meyer D; Fressinaud E; Hilbert L; Ribba AS; Lavergne JM; Mazurier C
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):349-64. PubMed ID: 11686104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes.
    Ruggeri ZM; Mannucci PM; Lombardi R; Federici AB; Zimmerman TS
    Blood; 1982 Jun; 59(6):1272-8. PubMed ID: 6805532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. von Willebrand disease: clinical and laboratory lessons learned from the large von Willebrand disease studies.
    James PD; Lillicrap D
    Am J Hematol; 2012 May; 87 Suppl 1(0 1):S4-11. PubMed ID: 22389132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How I treat patients with von Willebrand disease.
    Mannucci PM
    Blood; 2001 Apr; 97(7):1915-9. PubMed ID: 11264151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How I treat von Willebrand disease.
    Castaman G
    Thromb Res; 2020 Dec; 196():618-625. PubMed ID: 32819724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network.
    Abshire T; Cox-Gill J; Kempton CL; Leebeek FW; Carcao M; Kouides P; Donfield S; Berntorp E
    J Thromb Haemost; 2015 Sep; 13(9):1585-9. PubMed ID: 25930155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathophysiology of von Willebrand disease: therapeutic implications.
    Schneppenheim R
    Thromb Res; 2011; 128 Suppl 1():S3-7. PubMed ID: 22221847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
    Castaman G; Federici AB; Rodeghiero F; Mannucci PM
    Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
    Michiels JJ; van Vliet HH
    Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy.
    Lillicrap D
    Blood; 2013 Nov; 122(23):3735-40. PubMed ID: 24065240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inherited abnormalities of coagulation: hemophilia, von Willebrand disease, and beyond.
    Kumar R; Carcao M
    Pediatr Clin North Am; 2013 Dec; 60(6):1419-41. PubMed ID: 24237980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical studies of 162 patients with von Willebrand disease].
    Ouyang W; Yu Z; Yin J; Zhao X; Wang Z; Zhang W; Ma Z; Su J; Bai X; Ruan C
    Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):152-6. PubMed ID: 24606659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.